United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$828Mraised across 3 rounds since 2019, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Source recorded
Source recorded
From Dyne Therapeutics's own website and the SEC filings it signed: 14 on the team.
On the board, as filediDavid LubnerDirk KerstenEdward HurwitzLawrence Klein
AdvisersCatherine Stehman-Breen
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Forbion Capital Partners
Wellington Management
Franklin Templeton
Atlas VentureL
RA Capital Management
Hercules CapitalMPMMissing a round, or an investor who was in one? Tell us.
Dyne Therapeutics's investors include Forbion Capital Partners, Wellington Management, Franklin Templeton, Atlas Venture and RA Capital Management, and 2 more on record.
Dyne Therapeutics has raised $828M across 3 rounds since 2019.
Dyne Therapeutics's most recent round was an Undisclosed round of $375M in Jul 2026.
Dyne Therapeutics's largest round on record is $403M (Undisclosed round), in Dec 2025.
Dyne Therapeutics's first round on record, in Apr 2019, was backed by Atlas Venture, Forbion Capital Partners and MPM.
Dyne Therapeutics's latest named round is an Undisclosed round, in Jul 2026.
Dyne Therapeutics is based in the United States.
Atlas Venture led the Series A in 2019.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
